NextCure, Inc. financial data

Symbol
NXTC on Nasdaq
Location
9000 Virginia Manor Road, Suite 200, Beltsville, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 548 % -48.7%
Debt-to-equity 33.6 % +104%
Return On Equity -133 % -113%
Return On Assets -98.6 % -83.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.68M shares -90.4%
Common Stock, Shares, Outstanding 2.68M shares -90.4%
Entity Public Float 43.6M USD -11.4%
Common Stock, Value, Issued 3K USD -89.3%
Weighted Average Number of Shares Outstanding, Basic 2.68M shares +14.8%
Weighted Average Number of Shares Outstanding, Diluted 2.68M shares +14.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 47M USD +5.88%
General and Administrative Expense 13.3M USD -17.6%
Operating Income (Loss) -60.3M USD +4.39%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -58M USD +0.87%
Earnings Per Share, Basic -4 USD/shares +62.8%
Earnings Per Share, Diluted -4 USD/shares +62.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.32M USD -73.6%
Assets, Current 32.6M USD -58.5%
Property, Plant and Equipment, Net 3.64M USD -41%
Operating Lease, Right-of-Use Asset 2.79M USD -18.4%
Other Assets, Noncurrent 550K USD -73.4%
Assets 39.6M USD -56.2%
Accounts Payable, Current 2.39M USD -33.8%
Employee-related Liabilities, Current 1.75M USD +76.7%
Liabilities, Current 11M USD +26.8%
Operating Lease, Liability, Noncurrent 4.41M USD -18.1%
Other Liabilities, Noncurrent 561K USD -19%
Liabilities 16M USD +8.23%
Accumulated Other Comprehensive Income (Loss), Net of Tax 17K USD -77.6%
Retained Earnings (Accumulated Deficit) -427M USD -15.7%
Stockholders' Equity Attributable to Parent 23.6M USD -68.7%
Liabilities and Equity 39.6M USD -56.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13M USD -3.08%
Net Cash Provided by (Used in) Financing Activities 1K USD
Net Cash Provided by (Used in) Investing Activities 7.09M USD -60.3%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 2.68M shares -90.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.9M USD -212%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.32M USD -73.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 16K USD -15.8%
Deferred Tax Assets, Valuation Allowance 115M USD +16.5%
Deferred Tax Assets, Gross 116M USD +16%
Operating Lease, Liability 5.39M USD -12%
Payments to Acquire Property, Plant, and Equipment 37K USD -85.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -58.1M USD -0.4%
Lessee, Operating Lease, Liability, to be Paid 6.38M USD -15.4%
Property, Plant and Equipment, Gross 28.6M USD -2.42%
Operating Lease, Liability, Current 796K USD +21.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.4M USD +3.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.36M USD +11.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 992K USD -30.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.44M USD +3.01%
Deferred Tax Assets, Operating Loss Carryforwards 63.6M USD +12.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.48M USD +2.99%
Operating Lease, Payments 285K USD +2.89%
Additional Paid in Capital 450M USD +1.39%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.06M USD -23%
Share-based Payment Arrangement, Expense 4.07M USD -40.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%